Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class II · Moderate risk Terminated Initiated May 15, 2023 (3 years ago)

Piperacillin and Tazobactam for Injection

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Lack of Assurance of Sterility

Cause type: Sterility / contamination

A product that must be sterile could not be assured sterile, or was contaminated. A top reason for injectables, eye drops and IV products - loss of sterility assurance can lead to serious infections. All sterility / contamination recalls.

What was recalled

Piperacillin and Tazobactam for Injection, USP 4.5 grams per vial, Rx only, Mfd for Meitheal Pharmaceuticals Chicago, IL 60631, NDC 71288-004-51

Affected NDC 71288-0004-51

Compare with the code on your package — it is the most precise check available.

Drug: Tazobactam

Recalling firm
Astral SteriTech Private Ltd.
NDC code
71288-004-51
Origin
N/A, India
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0625-2023 · FDA notice

Check, then ask. Class II means harm is possible but usually temporary or reversible. Find the lot number on your package; if it matches, ask your pharmacist about a replacement. Do not simply stop a prescribed medication on your own - the gap can be riskier than the recall. This recall is now terminated, which means the firm has finished removing the affected product; anything on pharmacy shelves today should be unaffected.

Other Tazobactam recalls

See all

Other recalls by Astral SteriTech Private Ltd.

All 2023 recalls